WCN25-3095 LONG-TERM RESULTS OF TREATMENT WITH DIRECT ACTING ANTIVIRALS, CORTICOSTEROIDS, PLASMAPHERESIS AND RITUXIMAB IN A PATIENT WITH CRYOGLOBULINEMIC VASCULITIS AND HCV INFECTION

WCN25-3095 LONG-TERM RESULTS OF TREATMENT WITH DIRECT ACTING ANTIVIRALS, CORTICOSTEROIDS, PLASMAPHERESIS AND RITUXIMAB IN A PATIENT WITH CRYOGLOBULINEMIC VASCULITIS AND HCV INFECTION

Saved in:

Bibliographic Details
Main Authors:	Eleni Theodoropoulou, Spyridon Brakas, George Christofilidis, Marina Papadaki, Ioannis Hantzis, Anastasios Stofas, Charikleia Gakiopoulou
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924021685
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-2494 SURPRISINGLY GOOD RESPONSE OF A SEVERE ANCA-NEGATIVE CRESCENTIC PAUCI-IMMUNE GLOMERULONEPHRITIS SUCCESSFULLY TREATED WITH CORTICOSTEROIDS, CYCLOPHOSPHAMIDE AND RITUXIMAB
by: Eleni Theodoropoulou, et al.
Published: (2025-02-01)

HCV related severe cryoglobulinemic vasculitis treated with plasma exchange and rituximab: case report and literature review
by: Snezana Arandjelovic, et al.
Published: (2017-06-01)

Cryoglobulinemia and cryoglobulinemic vasculitis: etiological aspects and pathophysiological associations
by: I. Yu. Golovach, et al.
Published: (2020-03-01)

Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis
by: N. V. Dunaeva, et al.
Published: (2016-07-01)

WCN25-3712 CRYOGLOBULINEMIC GLOMERULONEPHRITIS AND VASCULITIS IN THE SETTING OF SJOGREN'S SYNDROME
by: Preethi Subramanian, et al.
Published: (2025-02-01)

Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
by: Haytham Hasan, et al.
Published: (2023-01-01)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
by: Adan Aftab, et al.
Published: (2022-01-01)

Eradication of hepatitits C virus in patient with cryoglobulinemic vasculitis and mutations D168E, L31V
by: N. V. Dunaeva, et al.
Published: (2020-03-01)

Clinical-evolutional particularities of the cryoglobulinemic vasculitis in the case of a patient diagnosed with hepatitis C virus in the predialitic phase
by: Daniel C. Caragea, et al.
Published: (2018-04-01)

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of cryoglobulinemic vasculitis at chronic hepatitis C
by: Yekaterina Ye. Starostina, et al.
Published: (2018-08-01)

Treatment of Nephrotic Syndrome With Antinephrin Antibodies Using Plasmapheresis, Rituximab, and Mycophenolate Mofetil
by: Keiichi Takizawa, et al.
Published: (2025-05-01)

Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction
by: Aysenur Keske, et al.
Published: (2022-01-01)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
by: Evangelista Sagnelli, et al.
Published: (2012-01-01)

Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up
by: S. V. Gavrisheva, et al.
Published: (2023-04-01)

The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update
by: Laurent Chiche, et al.
Published: (2012-01-01)

WCN25-4064 NECROSIS OF PENILE AND EXREMITIES OF LIMBS DUE TO CRYOGLOBULINEMIC VASCULITIS WITH HEPATITIS C : A RARE CASE REPORT IN HEMODIALYZED PATIENT
by: Eliane Ranivoharisoa, et al.
Published: (2025-02-01)

Checkpoint inhibitor-related renal vasculitis and use of rituximab
by: Noha Abdel-Wahab, et al.
Published: (2020-10-01)

A rare complication of IgA vasculitis: renal and intestinal ischemia successfully treated with plasmapheresis
by: Şeyma Türkmen, et al.
Published: (2023-10-01)

Renal prognostic value of serum monoclonal immunoglobulin in cryoglobulinemic glomerulonephritis
by: Lei Ma, et al.
Published: (2025-07-01)

Survey on Plasmapheresis Practices in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis: Insights From Two Clinical Case Studies
by: Cyril Mousseaux, et al.
Published: (2025-04-01)

Obinutuzumab in Rituximab-Intolerant Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Patients
by: Jolijn R. van Leeuwen, et al.
Published: (2025-04-01)

Fatal Cytomegalovirus Disease after Combination Therapy with Corticosteroids and Rituximab for Granulomatosis with Polyangiitis
by: Talal Hilal
Published: (2015-01-01)

Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis
by: Tania Salehi, et al.
Published: (2025-07-01)

Cryoglobulinemic Glomerulonephritis Presenting as Acute Kidney Injury on Chronic Kidney Disease in Rheumatoid Arthritis
by: Brinda Basida, et al.
Published: (2022-04-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis
by: Ningjun Shao, et al.
Published: (2025-08-01)

WCN25-2290 EFFICACY OF INDUCTION TREATMENT WITH CYCLOPHOSPHAMIDE, RITUXIMAB AND THEIR COMBINATION IN PATIENTS WITH PAUCIIMMUNE VASCULITIS
by: Martín Benjamín Yamá Estrella, et al.
Published: (2025-02-01)

ANCA-Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab
by: Saika Sharmeen, et al.
Published: (2018-01-01)

Ocular Manifestations of COVID-19 in a Patient with ANCAAssociated Vasculitis Treated with Rituximab. A Case Report
by: M. D. Suprun, et al.
Published: (2022-07-01)

WCN24-395 AVACOPAN IN MPO-ANCA VASCULITIS: WHEN CORTICOSTEROIDS CAN NOT BE THE LONG TERM ANSWER
by: Sofia Sousa, et al.
Published: (2024-04-01)

Plasmapheresis, Rituximab, and Ceftriaxone Provided Lasting Improvement for a 27-Year-Old Adult Male with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)
by: Adam Krouse, et al.
Published: (2021-01-01)

Place of plasmapheresis in the treatment of rheumatic diseases
by: S. K. Solovjov, et al.
Published: (2016-05-01)

Plasmapheresis as an Adjunctive Therapy in Phenytoin Poisoning
by: Purshotam Paudel, et al.
Published: (2024-11-01)

Late-onset neutropenia induced by anti-B cell therapy with rituximab in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2022-06-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
by: Ekbote Gayatri, et al.
Published: (2019-01-01)

Plasmapheresis for the Treatment of Anti-M Alloimmunization in Pregnancy
by: Yohei Maki, et al.
Published: (2020-01-01)

Application of ozone and plasmapheresis in complex treatment of uveitis
by: A. D. Chernyshyova
Published: (2009-06-01)

HIGH-VOLUME PLASMAPHERESIS IN CARDIAC AND AORTIC SURGERY
by: I. N. Solovievа, et al.
Published: (2018-05-01)

Functioning of Patients with Myasthenia Gravis after Plasmapheresis
by: Monika Biercewicz
Published: (2020-06-01)